Abstract
Determinations of serum concentrations of total insulin-like growth factor I (tIGF-I) are important in the diagnosis, monitoring of treatment and safety evaluation of patients with growth disorders and/or metabolic disease. It is well established that tIGF-I status varies over time. Changes in tIGF-I levels in relation to an acute bout of exercise or repeated bouts, known as training, are likely to contribute to this variation. Serum tIGF-I has also been found to be of predictive value in growth prediction models employed before the start of growth hormone (GH) treatment. Furthermore, IGF-I generation tests have been suggested to be of value in the assessment of the growth response to GH administration in patients suspected of GH deficiency with or without some degree of GH insensitivity. This is discussed elsewhere in this issue. Recent progress in our understanding of growth hormone-dependent and -independent expression of the IGF1 gene in skeletal muscle and the role of sufficient energy intake during training for muscle and liver generation of IGF-I raises important questions regarding their relative contribution to the circulating pool of IGF-I. The present review is focused on circulating levels of tIGF-I in relation to a single bout of exercise or to a period of training. In addition, the expression of IGF-I locally in muscle in response to these stimuli will be discussed.
Journal Section:
Efficacy
References
1.
Bang P, Brandt J, Degerblad M, Enberg G, Kaijser L, Thoren M, Hall K: Exercise-induced changes in insulin-like growth factors and their low molecular weight binding protein in healthy subjects and patients with growth hormone deficiency. Eur J Clin Invest 1990;20:285–292.
[PubMed]
2.
Cappon J, Brasel JA, Mohan S, Cooper DM: Effect of brief exercise on circulating insulin-like growth factor I. J Appl Physiol 1994;76:2490–2496.
3.
Schwarz AJ, Brasel JA, Hintz RL, Mohan S, Cooper DM: Acute effect of brief low- and high-intensity exercise on circulating insulin-like growth factor (IGF) I, II, and IGF-binding protein-3 and its proteolysis in young healthy men. J Clin Endocrinol Metab 1996;81:3492–3497.
4.
Hornum M, Cooper DM, Brasel JA, Bueno A, Sietsema KE: Exercise-induced changes in circulating growth factors with cyclic variation in plasma estradiol in women. J Appl Physiol 1997;82:1946–1951.
[PubMed]
5.
Wallace JD, Cuneo RC, Baxter R, Orskov H, Keay N, Pentecost C, Dall R, Rosen T, Jorgensen JO, Cittadini A, Longobardi S, Sacca L, Christiansen JS, Bengtsson BA, Sonksen PH: Responses of the growth hormone (GH) and insulin-like growth factor axis to exercise, GH administration, and GH withdrawal in trained adult males: A potential test for GH abuse in sport. J Clin Endocrinol Metab 1999;84:3591–3601.
6.
Kostka T, Patricot MC, Mathian B, Lacour JR, Bonnefoy M: Anabolic and catabolic hormonal responses to experimental two-set low-volume resistance exercise in sedentary and active elderly people. Aging Clin Exp Res 2003;15:123–130.
[PubMed]
7.
Ehrnborg C, Lange KH, Dall R, Christiansen JS, Lundberg PA, Baxter RC, Boroujerdi MA, Bengtsson BA, Healey ML, Pentecost C, Longobardi S, Napoli R, Rosen T; GH-2000 Study Group: The growth hormone/insulin-like growth factor-I axis hormones and bone markers in elite athletes in response to a maximum exercise test. J Clin Endocrinol Metab 2003;88:394–401.
8.
Kraemer RR, Durand RJ, Acevedo EO, Johnson LG, Kraemer GR, Hebert EP, Castracane VD: Rigorous running increases growth hormone and insulin-like growth factor-I without altering ghrelin. Exp Biol Med (Maywood) 2004;229:240–246.
[PubMed]
9.
Dall R, Lange KH, Kjaer M, Jorgensen JO, Christiansen JS, Orskov H, Flyvbjerg A: No evidence of insulin-like growth factor-binding protein 3 proteolysis during a maximal exercise test in elite athletes. J Clin Endocrinol Metab 2001;86:669–674.
10.
Elias AN, Pandian MR, Wang L, Suarez E, James N, Wilson AF: Leptin and IGF-I levels in unconditioned male volunteers after short-term exercise. Psychoneuroendocrinology 2000;25:453–461.
11.
Lee PD, Durham SK, Martinez V, Vasconez O, Powell DR, Guevara-Aguirre J: Kinetics of insulin-like growth factor (IGF) and IGF-binding protein responses to a single dose of growth hormone. J Clin Endocrinol Metab 1997;82:2266–2274.
12.
Wilson DP, Horowitz JL: Exercise-induced changes in growth hormone and somatomedin-C. Am J Med Sci 1987;293:216–217.
13.
Suikkari AM, Sane T, Seppala M, Yki-Jarvinen H, Karonen SL, Koivisto VA: Prolonged exercise increases serum insulin-like growth factor-binding protein concentrations. J Clin Endocrinol Metab 1989;68:141–144.
[PubMed]
14.
Koistinen H, Koistinen R, Selenius L, Ylikorkala Q, Seppala M: Effect of marathon run on serum IGF-I and IGF-binding protein 1 and 3 levels. J Appl Physiol 1996;80:760–764.
[PubMed]
15.
Scheett TP, Mills PJ, Ziegler MG, Stoppani J, Cooper DM: Effect of exercise on cytokines and growth mediators in prepubertal children. Pediatr Res 1999;46:429–434.
[PubMed]
16.
Chadan SG, Dill RP, Vanderhoek K, Parkhouse WS: Influence of physical activity on plasma insulin-like growth factor-1 and insulin-like growth factor binding proteins in healthy older women. Mech Ageing Dev 1999;109:21–34.
17.
Nemet D, Oh Y, Kim HS, Hill M, Cooper DM: Effect of intense exercise on inflammatory cytokines and growth mediators in adolescent boys. Pediatrics 2002;110:681–689.
18.
Nindl BC, Kraemer WJ, Marx JO, Arciero PJ, Dohi K, Kellogg MD, Loomis GA: Overnight responses of the circulating IGF-I system after acute, heavy-resistance exercise. J Appl Physiol 2001;90:1319–1326.
[PubMed]
19.
Raastad T, Bjoro T, Hallen J: Hormonal responses to high- and moderate-intensity strength exercise. Eur J Appl Physiol 2000;82:121–128.
20.
Booth BA, Boes M, Dake BL, Knudtson KL, Bar RS: IGFBP-3 binding to endothelial cells inhibits plasmin and thrombin proteolysis. Am J Physiol Endocrinol Metab 2002;282:E52–E58.
21.
Lewitt MS, Saunders H, Baxter RC: Bioavailability of insulin-like growth factors (IGFs) in rats determined by the molecular distribution of human IGF-binding protein-3. Endocrinology 1993;133:1797–1802.
22.
Kraemer WJ, Aguilera BA, Terada M, Newton RU, Lynch JM, Rosendaal G, McBride JM, Gordon SE, Hakkinen K: Responses of IGF-I to endogenous increases in growth hormone after heavy-resistance exercise. J Appl Physiol 1995;79:1310–1315.
[PubMed]
23.
Kraemer RR, Kilgore JL, Kraemer GR, Castracane VD: Growth hormone, IGF-I, and testosterone responses to resistive exercise. Med Sci Sports Exerc 1992;24:1346–1352.
[PubMed]
24.
Berg U, Saltin B, Hall K: Net fluxes of IGF-I, IGFBP-1, insulin, GH and energy substrates over contracting muscle during prolonged exercise in healthy men. Endocrinol Metab 1997;4:313–320.
25.
Bang P, Ahlsen M, Berg U, Carlsson-Skwirut C: Free insulin-like growth factor I: are we hunting a ghost? Horm Res 2001;55(suppl 2):84–93.
26.
Hall K, Holmgren A, Lindahl U: Purification of a sulphation factor from skeletal muscle of rat. Biochim Biophys Acta 1970;201:398–400.
[PubMed]
27.
Brahm H, Piehl-Aulin K, Saltin B, Ljunghall S: Net fluxes over working thigh of hormones, growth factors and biomarkers of bone metabolism during short lasting dynamic exercise. Calcif Tissue Int 1997;60:175–180.
28.
Anderson MF, Aberg MA, Nilsson M, Eriksson PS: Insulin-like growth factor-I and neurogenesis in the adult mammalian brain. Brain Res Dev Brain Res 2002;134:115–122.
29.
Carro E, Trejo JL, Busiguina S, Torres-Aleman I: Circulating insulin-like growth factor I mediates the protective effects of physical exercise against brain insults of different etiology and anatomy. J Neurosci 2001;21:5678–5684.
[PubMed]
30.
Bang P, Fielder PJ: Human pregnancy serum contains at least two distinct proteolytic activities with the ability to degrade insulin-like growth factor binding protein-3. Endocrinology 1997;138:3912–3917.
31.
Fowlkes JL, Thrailkill KM, Serra DM, Suzuki K, Nagase H: Matrix metalloproteinases as insulin-like growth factor binding protein-degrading proteinases. Prog Growth Factor Res 1995;6:255–263.
32.
Conover CA, De Leon DD: Acid-activated insulin-like growth factor-binding protein-3 proteolysis in normal and transformed cells. Role of cathepsin D. J Biol Chem 1994;269:7076–7080.
[PubMed]
33.
Kraemer WJ, Harman FS, Vos NH, Gordon SE, Nindl BC, Marx JO, Gomez AL, Volek JS, Ratamess NA, Mazzetti SA, Bush JA, Dohi K, Newton RU, Hakkinen K: Effects of exercise and alkalosis on serum insulin-like growth factor I and IGF-binding protein-3. Can J Appl Physiol 2000;25:127–138.
[PubMed]
34.
Keller P, Keller C, Carey AL, Jauffred S, Fischer CP, Steensberg A, Pedersen BK: Interleukin-6 production by contracting human skeletal muscle: Autocrine regulation by IL-6. Biochem Biophys Res Commun 2003;310:550–554.
35.
Steensberg A, Keller C, Starkie RL, Osada T, Febbraio MA, Pedersen BK: IL-6 and TNF-alpha expression in, and release from, contracting human skeletal muscle. Am J Physiol Endocrinol Metab 2002;283:E1272–E1278. Epub 2002 Aug 20.
36.
Yamamoto H, Murphy LJ: Generation of des-(1-3) insulin-like growth factor-I in serum by an acid protease. Endocrinology 1994;135:2432–2439.
37.
Fernqvist-Forbes E, Ekberg K, Lindgren BF, Brismar K: Splanchnic exchange of insulin-like growth factor binding protein-1 (IGFBP-1), IGF-I and acid-labile subunit (ALS) during normo- and hyper-insulinaemia in healthy subjects. Clin Endocrinol (Oxf) 1999;51:327–332.
38.
Yakar S, Liu JL, Fernandez AM, Wu Y, Schally AV, Frystyk J, Chernausek SD, Mejia W, Le Roith D: Liver-specific igf-1 gene deletion leads to muscle insulin insensitivity. Diabetes 2001;50:1110–1118.
[PubMed]
39.
Yang S, Alnaqeeb M, Simpson H, Goldspink G: Cloning and characterization of an IGF-1 isoform expressed in skeletal muscle subjected to stretch. J Muscle Res Cell Motil 1996;17:487–495.
40.
Chew SL, Lavender P, Clark AJ, Ross RJ: An alternatively spliced human insulin-like growth factor-I transcript with hepatic tissue expression that diverts away from the mitogenic IBE1 peptide. Endocrinology 1995;136:1939–1944.
41.
Yang SY, Goldspink G: Different roles of the IGF-I Ec peptide (MGF) and mature IGF-I in myoblast proliferation and differentiation. FEBS Lett 2002;522:156–160.
42.
Hameed M, Orrell RW, Cobbold M, Goldspink G, Harridge SD: Expression of IGF-I splice variants in young and old human skeletal muscle after high resistance exercise. J Physiol 2003;547(Pt 1):247–254. Epub 2002 Dec 20.
43.
Owino V, Yang SY, Goldspink G: Age-related loss of skeletal muscle function and the inability to express the autocrine form of insulin-like growth factor-1 (MGF) in response to mechanical overload. FEBS Lett 2001;505:259–263.
44.
Bamman MM, Shipp JR, Jiang J, Gower BA, Hunter GR, Goodman A, McLafferty CL Jr, Urban RJ: Mechanical load increases muscle IGF-I and androgen receptor mRNA concentrations in humans. Am J Physiol Endocrinol Metab 2001;280:E383–E390.
45.
Psilander N, Damsgaard R, Pilegaard H: Resistance exercise alters MRF and IGF-I mRNA content in human skeletal muscle. J Appl Physiol 2003;95:1038–1044. Epub 2003 Apr 25.
[PubMed]
46.
Hellsten Y, Hansson HA, Johnson L, Frandsen U, Sjodin B: Increased expression of xanthine oxidase and insulin-like growth factor I (IGF-I) immunoreactivity in skeletal muscle after strenuous exercise in humans. Acta Physiol Scand 1996;157:191–197.
47.
DeVol DL, Rotwein P, Sadow JL, Novakofski J, Bechtel PJ: Activation of insulin-like growth factor gene expression during work-induced skeletal muscle growth. Am J Physiol 1990;259(1 Pt I):E89–E95.
48.
Adams GR, Haddad F: The relationships among IGF-1, DNA content, and protein accumulation during skeletal muscle hypertrophy. J Appl Physiol 1996;81:2509–2516.
49.
Frost RA, Lang CH: Regulation of insulin-like growth factor-I in skeletal muscle and muscle cells. Minerva Endocrinol 2003;28:53–73.
[PubMed]
50.
Czerwinski SM, Martin JM, Bechtel PJ: Modulation of IGF mRNA abundance during stretch-induced skeletal muscle hypertrophy and regression. J Appl Physiol 1994;76:2026–2030.
[PubMed]
51.
Smith AT, Clemmons DR, Underwood LE, Ben-Ezra V, McMurray R: The effect of exercise on plasma somatomedin-C/insulinlike growth factor I concentrations. Metabolism 1987;36:533–537.
52.
Kelly PJ, Eisman JA, Stuart MC, Pocock NA, Sambrook PN, Gwinn TH: Somatomedin-C, physical fitness, and bone density. J Clin Endocrinol Metab 1990;70:718–723.
[PubMed]
53.
Poehlman ET, Copeland KC: Influence of physical activity on insulin-like growth factor-I in healthy younger and older men. J Clin Endocrinol Metab 1990;71:1468–1473.
[PubMed]
54.
Haydar ZR, Blackman MR, Tobin JD, Wright JG, Fleg JL: The relationship between aerobic exercise capacity and circulating IGF-1 levels in healthy men and women. J Am Geriatr Soc 2000;48:139–145.
[PubMed]
55.
Kostka T, Arsac LM, Patricot MC, Berthouze SE, Lacour JR, Bonnefoy M: Leg extensor power and dehydroepiandrosterone sulfate, insulin-like growth factor-I and testosterone in healthy active elderly people. Eur J Appl Physiol 2000;82:83–90.
56.
Rudman D, Mattsan DE: Serum IGF-I in healthy older men in relation to physical activity. J Am Geriatr Soc 1994;42:71–76.
[PubMed]
57.
Eliakim A, Scheett TP, Newcomb R, Mohan S, Cooper DM: Fitness, training, and the growth hormone → insulin-like growth factor I axis in prepubertal girls. J Clin Endocrinol Metab 2001;86:2797–2802.
58.
Eliakim A, Brasel JA, Mohan S, Barstow TJ, Berman N, Cooper DM: Physical fitness, endurance training, and the growth hormone-insulin-like growth factor I system in adolescent females. J Clin Endocrinol Metab 1996;81:3986–3992.
59.
Eliakim A, Brasel JA, Barstow TJ, Mohan S, Cooper DM: Peak oxygen uptake, muscle volume, and the growth hormone-insulin-like growth factor-I axis in adolescent males. Med Sci Sports Exerc 1998;30:512–517.
[PubMed]
60.
Scheett TP, Nemet D, Stoppani J, Maresh CM, Newcomb R, Cooper DM: The effect of endurance-type exercise training on growth mediators and inflammatory cytokines in pre-pubertal and early pubertal males. Pediatr Res 2002;52:491–497.
61.
Filaire E, Jouanel P, Colombier M, Begue RJ, Lac G: Effects of 16 weeks of training prior to a major competition on hormonal and biochemical parameters in young elite gymnasts. J Pediatr Endocrinol Metab 2003;16:741–750.
[PubMed]
62.
Schmitz KH, Ahmed RL, Yee D: Effects of a 9-month strength training intervention on insulin, insulin-like growth factor (IGF)-I, IGF-binding protein (IGFBP)-1, and IGFBP-3 in 30–50-year-old women. Cancer Epidemiol Biomarkers Prev 2002;11:1597–1604.
[PubMed]
63.
Rosendal L, Langberg H, Flyvbjerg A, Frystyk J, Orskov H, Kjaer M: Physical capacity influences the response of insulin-like growth factor and its binding proteins to training. J Appl Physiol 2002;93:1669–1675.
[PubMed]
64.
Milliken LA, Going SB, Houtkooper LB, Flint-Wagner HG, Figueroa A, Metcalfe LL, Blew RM, Sharp SC, Lohman TG: Effects of exercise training on bone remodeling, insulin-like growth factors, and bone mineral density in postmenopausal women with and without hormone replacement therapy. Calcif Tissue Int 2003;72:478–484. Epub 2003 Feb 10.
65.
Sartorio A, Lafortuna C, Capodaglio P, Vangeli V, Narici MV, Faglia G: Effects of a 16-week progressive high-intensity strength training (HIST) on indexes of bone turnover in men over 65 years: A randomized controlled study. J Endocrinol Invest 2001;24:882–886.
[PubMed]
66.
Chicharro JL, Lopez-Calderon A, Hoyos J, Martin-Velasco AI, Villa G, Villanua MA, Lucia A: Effects of an endurance cycling competition on resting serum insulin-like growth factor I (IGF-I) and its binding proteins IGFBP-1 and IGFBP-3. Br J Sports Med 2001;35:303–307.
67.
Poehlman ET, Rosen CJ, Copeland KC: The influence of endurance training on insulin-like growth factor-1 in older individuals. Metabolism 1994;43:1401–1405.
68.
Nemet D, Connolly PH, Pontello-Pescatello AM, Rose-Gottron C, Larson JK, Galassetti P, Cooper DM: Negative energy balance plays a major role in the IGF-I response to exercise training. J Appl Physiol 2004;96:276–282. Epub 2003 Aug 29.
69.
Koziris LP, Hickson RC, Chatterton RT Jr, Groseth RT, Christie JM, Goldflies DG, Unterman TG: Serum levels of total and free IGF-I and IGFBP-3 are increased and maintained in long-term training. J Appl Physiol 1999;86:1436–1442.
[PubMed]
70.
Borst SE, De Hoyos DV, Garzarella L, Vincent K, Pollock BH, Lowenthal DT, Pollock ML: Effects of resistance training on insulin-like growth factor-I and IGF binding proteins. Med Sci Sports Exerc 2001;33:648–653.
[PubMed]
71.
Parkhouse WS, Coupland DC, Li C, Vanderhoek KJ: IGF-1 bioavailability is increased by resistance training in older women with low bone mineral density. Mech Ageing Dev 2000;113:75–83.
72.
Bermon S, Ferrari P, Bernard P, Altare S, Dolisi C: Responses of total and free insulin-like growth factor-I and insulin-like growth factor binding protein-3 after resistance exercise and training in elderly subjects. Acta Physiol Scand 1999;165:51–56.
73.
Lee S, Barton ER, Sweeney HL, Farrar RP: Viral expression of insulin-like growth factor-I enhances muscle hypertrophy in resistance-trained rats. J Appl Physiol 2004;96:1097–1104.
© 2004 S. Karger AG, Basel
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
2005
You do not currently have access to this content.
